Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Asthma | R-HSA-444620 | map05310 | ciclacillin | 71415 | drug-path |
| Regulation of actin cytoskeleton | R-HSA-392751 | map04810 | ciclacillin | 71415 | drug-path |
| Allograft rejection | R-HSA-9679028 | map05330 | ciclacillin | 71415 | drug-path |
| Type I diabetes mellitus | R-HSA-5683209 | map04940 | ciclacillin | 71415 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | ciclacillin | 71415 | drug-path |
| Notch signaling pathway | R-HSA-157118 | map04330 | ciclacillin | 71415 | drug-path |
| Gap junction | R-HSA-190861 | map04540 | ciclacillin | 71415 | drug-path |
| GnRH signaling pathway | R-HSA-168638 | map04912 | ciclacillin | 71415 | drug-path |
| Huntington's disease | R-HSA-1643685 | 0 | flutamide | 3397 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | flutamide | 3397 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | flutamide | 3397 | drug-path |
| Bladder cancer | R-HSA-9700206 | map05219 | flutamide | 3397 | drug-path |
| Renal cell carcinoma | R-HSA-9794523 | map05211 | flutamide | 3397 | drug-path |
| B cell receptor signaling pathway | R-HSA-983705 | map04662 | flutamide | 3397 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | flutamide | 3397 | drug-path |
| Pathways in cancer | R-HSA-9824443 | map05200 | flutamide | 3397 | drug-path |
| Acute myeloid leukemia | R-HSA-9680350 | map05221 | flutamide | 3397 | drug-path |
| VEGF signaling pathway | R-HSA-194138 | map04370 | flutamide | 3397 | drug-path |
| Thyroid cancer | R-HSA-9700206 | map05216 | flutamide | 3397 | drug-path |
| Non-small cell lung cancer | R-HSA-5619066 | map05223 | flutamide | 3397 | drug-path |